Company Overview and News

0
Innovative Lithium Extraction Technique, Summary of Testing

2018-06-11 accesswire
KELOWNA, BC / ACCESSWIRE / June 11, 2018 / Enertopia Corporation (ENRT) on the OTCQB and (TOP) on the CSE, (OTCQB: ENRT) (CSE: TOP) (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium compounds by our technology partner, Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT IONEXCHANG TOP 500214

0
Second Stage Testing Completed “Assays Pending”

2018-06-04 globenewswire
KELOWNA, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- Enertopia Corporation (OTCQB:ENRT) and (CSE:TOP) (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium by our technology partner Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT NRM NRVTD TOP NRVTF

38
Lithium Investment: Balancing Battery Demand Against Innovative Production And Supply

2018-05-29 seekingalpha
So much so, that many users are jumping in with investment dollars to stimulate and foster growth.
PLS PCRFY PILBF ALB LTUM FTI.WI TYHOF TOP FMC LACDF NMKEF ENRT AVLIF NMX 8015 RHHNF OROCF MLNLF LAC

0
Innovative Lithium Extraction Technique in Final Stage of Testing

2018-05-15 globenewswire
KELOWNA, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Enertopia Corporation (OTC:ENRT) on the OTCQB and (CSE:TOP) on the CSE (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium by our technology partner Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT AA.H CYP TOP AXVEF CYDVF

0
Lithium Brine Bench Testing Update

2018-04-24 globenewswire
KELOWNA, British Columbia, April 24, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Enertopia Corporation (ENRT) on the OTCQB and (TOP) on the CSE (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium by our technology partner Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT TOP

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

9h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to CNSX:TOP / Enertopia Corp on message board site Silicon Investor.

Off Topic - Anything Goes Off Topic (Every Day Technology)
Cisco Systems, Inc. - Off-topic postings WSEA - off topic and general comments thread
GameStop Corp (GME) Stop the War!
Ventas VTR, another u0026#034;PSYCLE smu0026#034; depr. buy, w/stop Top Image Systems Ltd. (TISA)
Need help, filing for an injunction to stop a house demoliti Enertopia Corporation